Stereotactic body radiation therapy for primary lung cancers >3 centimeters

Journal of Thoracic Oncology

Volumn 8, Issue 11, 2013, Pages 1396-1401

  Cuaron, John J ^a   Yorke, Ellen D ^a   Foster, Amanda ^a   Hsu, Meier ^a   Zhang, Zhigang ^a   Liu, Fan ^a   Jackson, Andrew ^a   Mychalczak, Borys ^a   Rosenzweig, Kenneth E ^b   Wu, Abraham J ^a   Rimner, Andreas ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOUNT SINAI HOSPITAL   (United States)

Author keywords

Large tumors; Lung cancer; Stereotactic body radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LOCAL FAILURE FREE SURVIVAL; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RECURRENCE FREE SURVIVAL; STEREOTACTIC BODY RADIATION THERAPY; THORAX PAIN; TOXICITY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOSURGERY; SURVIVAL RATE;

EID: 84886597931     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182a47181     Document Type: Article

References (20)

1. Dosoretz DE, Galmarini D, Rubenstein JH, et al. Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys 1993;27:507-516
2. Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR. Radiotherapy alone for medically inoperable stage I non-smallcell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 1998;40:149-154
3. Kaskowitz L, Graham MV, Emami B, Halverson KJ, Rush C. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993;27:517-523
4. Wigren T, Kellokumpu-Lehtinen P, Ojala A. Radical radiotherapy of inoperable non-small cell lung cancer. Irradiation techniques and tumor characteristics in relation to local control and survival. Acta Oncol 1992;31:555-561
5. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/ II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427-1431
6. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009;75:677-682
7. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303: 1070-1076
8. Fernando HC, Timmerman R. American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: A randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2012;144:S35-S38
9. Lovelock DM, Hua C, Wang P, et al. Accurate setup of paraspinal patients using a noninvasive patient immobilization cradle and portal imaging. Med Phys 2005;32:2606-2614
10. Mohan R, Barest G, Brewster LJ, et al. A comprehensive three-dimensional radiation treatment planning system. Int J Radiat Oncol Biol Phys 1988;15:481-495
11. Spirou SV, Chui CS. A gradient inverse planning algorithm with dosevolume constraints. Med Phys 1998;25:321-333
12. Lausen B, Schumacher M. Maximally selected rank statistics. Biometrics 1992;48:73-85
13. Mutter RW, Liu F, Abreu A, Yorke E, Jackson A, Rosenzweig KE. Dosevolume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer. Int J Radiat Oncol Biol Phys 2012;82:1783-1790
14. Bradley J, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2005;61:318-328
15. Rosenzweig KE, Fox JL, Yorke E, et al. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer 2005;103:2118-2127
16. Sura S, Yorke E, Jackson A, Rosenzweig KE. High-dose radiotherapy for the treatment of inoperable non-small cell lung cancer. Cancer J 2007;13:238-242
17. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946-1955
18. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 2005;63:1010-1015
19. Videtic GM, Stephans K, Reddy C, et al. Intensity-modulated radiotherapy- based stereotactic body radiotherapy for medically inoperable earlystage lung cancer: Excellent local control. Int J Radiat Oncol Biol Phys 2010;77:344-349
20. Dunlap NE, Larner JM, Read PW, et al. Size matters: A comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT). J Thorac Cardiovasc Surg 2010;140:583-589